Aegon placed on J.P. Morgan’s Positive Catalyst Watch ahead of possible U.S. move

J.P. Morgan placed Aegon on a Positive Catalyst Watch ahead of its Capital Markets Day, raising its price target to €8.50 and reiterating an "overweight" rating, primarily due to the potential for a strategic re-domiciliation to the United States. This shift is expected to unlock "substantial SOTP upside" by aligning the insurer with its largest market (60% of operational capital) and simplifying its structure, with J.P. Morgan forecasting a €1.4 billion share buyback, further divestments to focus on the U.S., and projecting EPS to reach €1.08 in 2025 with a 6.8% dividend yield by 2027.

Analysis

J.P. Morgan has placed Aegon on a 'Positive Catalyst Watch' ahead of its December 10th Capital Markets Day, signaling strong conviction in a potential strategic re-domiciliation to the United States. The brokerage raised its price target to €8.50 from €7.65, underpinning its 'overweight' rating with a sum-of-the-parts (SOTP) valuation of €8.52 for 2026. This move is seen as transformative, as it would align the insurer's corporate structure with its primary market, given the Americas already contribute approximately 60% of operational capital generation and group revenues. The transition, following the sale of its Dutch operations and a temporary regulatory shift to Bermuda, is expected to unlock significant value by simplifying accounting under U.S. GAAP, easing cash remittances, and removing a perceived valuation drag. J.P. Morgan's financial forecasts project a sharp increase in adjusted earnings per share from €0.52 in 2024 to €1.08 in 2025, with return on equity expected to stabilize around 20-22%. Furthermore, the analysis anticipates substantial capital returns, including a €1.4 billion share buyback in 2026 and dividend growth leading to a 6.8% yield by 2027, all contingent on management's successful execution of this strategic pivot towards its core U.S. operations.

Key Decisions for Investors

• Investors should monitor Aegon's upcoming Capital Markets Day on December 10th for a formal announcement on the U.S. re-domiciliation, which serves as the primary near-term catalyst for the stock.
• The investment thesis is centered on a multi-year strategic restructuring; positions should be evaluated based on the potential valuation unlock from the sum-of-the-parts against the execution risks associated with the corporate move and planned divestitures of non-core assets.
• Beyond the restructuring angle, the strong underlying financial projections, including significant EPS growth in 2025, a planned €1.4 billion share buyback, and a robust dividend yield, provide a fundamental cushion that should be factored into valuation models.
• Consider the potential for further portfolio simplification, as management may use the U.S. relocation as an opportunity to divest its UK and other international businesses to sharpen its focus and investor proposition.